DoH NI MEDICINES ACCESS REVIEW — RECOMMENDATION 2

The DoH NI Medicines Access Review (2025) specifically names the Blueteq HCD system as the recommended replacement for cost-per-case commissioning.

Add Your Heading Text Here

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.